Monitoring with mean kinetic temperature in GxP environments

Supplied by Vaisala Oyj on Tuesday, 14 February, 2017

Regulatory bodies in drug manufacturing and distribution have long been working together to create standards for temperature monitoring that will ensure the quality of drugs, devices and biotechnology. The mean kinetic temperature (MKT) value has been identified as a potential tool for evaluating the impact of temperature on product quality.

Download this paper to discover how to perform the calculation and some basic recommendations for its appropriate use.

Related White Papers

Genomic DNA: extraction from whole blood

To find out how a DNA purification system isolates and purifies genomic DNA (gDNA) from whole...

Assessing yeast viability

Microorganisms such as yeast are used in many biotechnology applications including genetic...

Normal and tumorous liver slices: high value for diverse applications

Learn about a highly reproducible method for the...

Content from other channels on our network

Poultry packaging partnership extends beyond the tray

Safcol to build $80m food manufacturing facility in SA

Avocado supply chain handling training program partners with Woollies

Technology report — Muting in practice: when safety becomes a vulnerability

Why Class 0 Oil-Free Compressors Are Essential for the Food & Beverage Industry

Six key pillars of frailty prevention and management

Protecting the people who protect us: PPE continuity during demand surge

WA steps in to ensure 'continuity' of operations at Mount Private Hospital

What healthcare boards need from risk leaders

Additional $22.9m in research grants for nation's biggest killer

Businesses use AI to manage sustainability reporting

Victorian wind farm project to power 1.2 million homes

SA retirement village reduces energy costs using solar system

Battery-free sensors close to reality

How do we prepare for a hotter, more populated, Sydney?

All content Copyright © 2026 Westwick-Farrow Pty Ltd